Halper Sadeh Launches Investigations into Four Corporate Acquisitions
Legal firm Halper Sadeh LLC has initiated investigations into Avanos Medical, Nuvalent, XOMA Royalty, and TruBridge over potential breaches of fiduciary duty. The firm is scrutinizing whether recent sale agreements prioritize insider interests at the expense of ordinary shareholders or unfairly restrict the potential for superior competing bids.
The New York-based firm is examining the specific terms surrounding four distinct transactions: the $25.00 per share cash sale of Avanos Medical to American Industrial Partners, Nuvalent’s $124.00 per share deal with GSK, XOMA Royalty’s $39.00 per share acquisition by Ligand Pharmaceuticals, and the $26.25 per share purchase of TruBridge by Inventurus Knowledge Solutions. These inquiries focus on whether the proposed deal structures adequately protect investor value or if they contain provisions that deter alternative offers.
Halper Sadeh attorneys, led by Daniel Sadeh and Zachary Halper, are evaluating whether these companies fulfilled their legal obligations to shareholders. The firm indicated it may seek increased compensation or additional financial disclosures to ensure transparency. Investors involved in these companies are being invited to discuss potential legal options, with the firm operating on a contingent fee basis for those pursuing claims.
Comments (0)
No comments yet. Be the first!